Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from EBOS Group Limited ( (AU:EBO) ) is now available.
Sybos Holdings Pte Limited has significantly reduced its stake in EBOS Group Limited, decreasing its holding from 18.058% to 4.900% through a block trade agreement with UBS New Zealand Limited. This transaction, involving the sale of 26,740,177 ordinary shares for NZ$949,276,283.50, may impact EBOS’s shareholder composition and market perception.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$39.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services including pharmaceuticals, medical supplies, and animal care products. The company is listed on both the New Zealand and Australian stock exchanges under the ticker EBO.
Average Trading Volume: 73,288
Technical Sentiment Signal: Buy
Current Market Cap: A$7B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue